KPX Lifescience Co Ltd
KOSDAQ:114450
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
KPX Lifescience Co Ltd
Cash & Cash Equivalents
KPX Lifescience Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
KPX Lifescience Co Ltd
KOSDAQ:114450
|
Cash & Cash Equivalents
₩13.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
41%
|
CAGR 10-Years
15%
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Cash & Cash Equivalents
₩922.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
100%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Cash & Cash Equivalents
₩4.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Cash & Cash Equivalents
₩1.5B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
10%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Cash & Cash Equivalents
₩30.5B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Cash & Cash Equivalents
₩24.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
26%
|
|
KPX Lifescience Co Ltd
Glance View
KPX LIFESCIENCE Co., Ltd. engages in the production and sale of pharmaceutical and agricultural raw materials and intermediates. The company is headquartered in Yeosu, Jeollanam-Do and currently employs 61 full-time employees. The company went IPO on 2009-12-22. The Company’s products consist of AMZ and CCIM, which are used as crop protection materials; EDP-CL, which is a antibiotic used as ingredient of piperacillin; PM06, which is used for treatment of allergic diseases, and DSIC, which is used as pharmaceutical intermediate. The firm also provides antibiotics and others. The firm distributes its products within domestic market and to overseas markets, including Japan, the United States, Europe and others.
See Also
What is KPX Lifescience Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
13.4B
KRW
Based on the financial report for Dec 31, 2025, KPX Lifescience Co Ltd's Cash & Cash Equivalents amounts to 13.4B KRW.
What is KPX Lifescience Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
15%
Over the last year, the Cash & Cash Equivalents growth was 48%.
